Sweden: Peptonic Medical ends distribution agreement with Yuanjia Bio

Peptonic Medical, biomedical company that conducts research, develops and sells products in the field of women’s health, has announced that the distribution agreement with Yuanjia Biotechnology concerning VagiVital AktivGel for the Chinese market has been terminated due to a payment default. Yuanjia Bio has failed to pay Peptonic a total of €406,000 (US$477,910). The failure…

You must be a HMI Subscriber to view this content.

Subscribe Now »